Cecil Arthur Bradley, MD
Addiction (Substance Use Disorder) · San Jose
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Probation Completed
- 3 Medical Board actions on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bradley’s office at (408) 356-3663 to ask if they take your plan before you enroll.
California Medical Board record
Licence C34133 · Surrendered
Licence status: Surrendered · since 1972 · University of Texas Southwestern Medical School at Dallas. Board flags: Probation Completed, Prior Probation Completed.
Licensee has surrendered his or her license to resolve a disciplinary or licensing action. No practice is permitted.
Public record actions
| 2025-10-16 | Board disciplineDiscipline | Surrender of license. · 8002025114988 |
| 2012-04-02 | Board disciplineDiscipline | Probation completed. · 12 2004157064 |
| 2002-07-30 | Board disciplineDiscipline | Prior probation completed. · 03 1993029006 |
Original Medicare doctor bills
$53,343
Medicare paid this office $53,343 for 51 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 44 | $30,796 | $118 |
| Psychotherapy with evaluation and management visit, 30 minutes | 41 | $15,179 | $63 |
| Psychotherapy with evaluation and management visit, 45 minutes | 23 | $3,664 | $76 |
| Short return visit (20+ min) | 16 | $2,722 | $82 |
Who their Medicare patients are
51 Original Medicare patients in 2024. Average age 71 · Women 57% · Health risk score 1.24. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 63% · Depression 55% · Coronary heart disease 27% · Diabetes 22%.
The office billed $86,465, Medicare allowed $69,890 and paid $53,343; for 590 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 51 | 590 | 71 | 1.24 | $86,465 | $53,343 |
| 2023 | 53 | 713 | 71 | 1.41 | $103,120 | $63,880 |
| 2022 | 54 | 628 | 69 | 1.30 | $92,120 | $57,059 |
| 2021 | 45 | 538 | 66 | 1.53 | $79,865 | $49,961 |
| 2020 | 101 | 685 | 63 | 1.47 | $130,925 | $64,469 |
| 2019 | 113 | 607 | 64 | 1.82 | $111,875 | $57,200 |
| 2018 | 118 | 537 | 66 | 1.89 | $104,555 | $51,510 |
| 2017 | 92 | 446 | 63 | 1.74 | $91,150 | $43,205 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 46 | $31,322 | $119 |
| Psychotherapy with evaluation and management visit, 30 minutes | 44 | $15,779 | $62 |
| Psychotherapy with evaluation and management visit, 45 minutes | 29 | $7,236 | $80 |
| Short return visit (20+ min) | 24 | $6,697 | $80 |
| Psychiatric diagnostic evaluation with medical services | 12 | $2,136 | $178 |
2022: 5 services
| Return visit (30+ min) | 42 | $25,424 | $118 |
| Psychotherapy with evaluation and management visit, 30 minutes | 42 | $13,852 | $63 |
| Short return visit (20+ min) | 18 | $6,563 | $79 |
| Psychotherapy with evaluation and management visit, 45 minutes | 17 | $6,262 | $81 |
| Psychiatric diagnostic evaluation with medical services | 26 | $4,603 | $177 |
2021: 3 services
| Return visit (30+ min) | 30 | $25,736 | $121 |
| Psychotherapy with evaluation and management visit, 30 minutes | 30 | $13,867 | $64 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $2,731 | $83 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $29,682 | $94 |
| Return visit (30+ min) | 26 | $12,728 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,674 | $179 |
| Psychotherapy with evaluation and management visit, 30 minutes | 26 | $8,101 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,003 | $67 |
| Hospital discharge day management, 30 minutes or less | 14 | $958 | $68 |
2019: 4 services
| Return visit (30+ min) | 37 | $16,935 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $15,524 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,576 | $181 |
| Psychotherapy with evaluation and management visit, 30 minutes | 37 | $10,284 | $61 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $14,459 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $13,791 | $177 |
| Return visit (30+ min) | 26 | $13,059 | $97 |
| Psychotherapy with evaluation and management visit, 30 minutes | 26 | $7,828 | $58 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $13,704 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,175 | $176 |
| Return visit (30+ min) | 17 | $9,096 | $97 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $5,264 | $56 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,315 | $66 |
Drugs they prescribed that Part D paid
$27,692
Pharmacies billed $27,692 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (83 of 1,030) in 2024. A higher opioid share than 9 in 10 peers; the typical psychiatry clinician is at 0%.
1,013 generic and 17 brand-name prescriptions · $27,692 in drug cost · 40 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine-Naloxone | 66 | $5,246 | $79 |
| Aripiprazole | 20 | $2,385 | $119 |
| Alprazolam | 82 | $1,076 | $13 |
| Hydromorphone | 82 | $919 | $11 |
| Bupropion Xl | 31 | $846 | $27 |
See all 28 drugs
| Buprenorphine-Naloxone | 66 | $5,246 | $79 |
| Aripiprazole | 20 | $2,385 | $119 |
| Alprazolam | 82 | $1,076 | $13 |
| Hydromorphone | 82 | $919 | $11 |
| Bupropion Xl | 31 | $846 | $27 |
| Pregabalin | 27 | $689 | $26 |
| Lorazepam | 69 | $686 | $10 |
| Divalproex | 16 | $669 | $42 |
| Buprenorphine | 25 | $629 | $25 |
| Olanzapine | 56 | $566 | $10 |
| Oxcarbazepine | 12 | $540 | $45 |
| Duloxetine | 16 | $531 | $33 |
| Gabapentin | 23 | $495 | $22 |
| Bupropion Hcl Sr | 37 | $482 | $13 |
| Dextroamphetamine-Amphetamine | 26 | $413 | $16 |
| Escitalopram | 29 | $411 | $14 |
| Quetiapine | 24 | $401 | $17 |
| Ondansetron Odt | 24 | $365 | $15 |
| Trazodone | 27 | $316 | $12 |
| Divalproex Sodium Er | 16 | $236 | $15 |
| Risperidone | 23 | $199 | $9 |
| Propranolol | 11 | $198 | $18 |
| Clonazepam | 37 | $166 | $4 |
| Eszopiclone | 13 | $105 | $8 |
| Clonidine | 11 | $80 | $7 |
| Buspirone | 18 | $25 | $1 |
| Sertraline | 21 | $19 | $1 |
| Paroxetine | 11 | $13 | $1 |
Year by year
| 2024 | 1,030 | 53 | 8% (83) | 2% | $27,692 |
| 2023 | 818 | 51 | 9% (70) | None | $41,150 |
| 2022 | 634 | 44 | 4% (25) | None | $27,748 |
| 2021 | 540 | 40 | 4% (24) | 6% | $27,915 |
| 2020 | 505 | 48 | 3% (14) | 4% | $21,779 |
| 2019 | 339 | 46 | None | None | $19,522 |
| 2018 | 312 | 47 | 5% (17) | 10% | $18,471 |
| 2017 | 360 | 43 | 4% (13) | 12% | $22,023 |
| 2016 | 376 | 44 | None | None | $36,219 |
| 2015 | 381 | 40 | None | 21% | $52,640 |
| 2014 | 358 | 33 | None | 23% | $40,705 |
| 2013 | 315 | 30 | None | 16% | $32,449 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Buprenorphine-Naloxone | 41 | $7,441 | $181 |
| Buprenorphine | 27 | $1,915 | $71 |
| Fluvoxamine Maleate | 21 | $1,650 | $79 |
| Dextroamphetamine-Amphetamine | 26 | $1,515 | $58 |
| Gabapentin | 22 | $1,296 | $59 |
| Lorazepam | 53 | $1,218 | $23 |
| Bupropion Hcl Sr | 11 | $881 | $80 |
| Olanzapine | 45 | $849 | $19 |
| Bupropion Xl | 33 | $722 | $22 |
| Hydromorphone | 67 | $697 | $10 |
| Alprazolam | 68 | $667 | $10 |
| Trazodone | 27 | $631 | $23 |
| Oxcarbazepine | 12 | $621 | $52 |
| Divalproex | 23 | $514 | $22 |
| Quetiapine | 20 | $484 | $24 |
| Clonazepam | 26 | $404 | $16 |
| Venlafaxine Hcl Er | 13 | $298 | $23 |
| Risperidone | 32 | $264 | $8 |
| Escitalopram | 11 | $249 | $23 |
| Duloxetine | 19 | $204 | $11 |
| Pregabalin | 19 | $93 | $5 |
| Eszopiclone | 12 | $85 | $7 |
| Sertraline | 23 | $57 | $2 |
| Paroxetine | 12 | $53 | $4 |
2022: 21 drugs
| Buprenorphine-Naloxone | 34 | $6,373 | $187 |
| Dextroamphetamine-Amphetamine | 25 | $1,034 | $41 |
| Fluvoxamine Maleate | 20 | $882 | $44 |
| Buprenorphine | 26 | $780 | $30 |
| Olanzapine | 29 | $704 | $24 |
| Trazodone | 20 | $598 | $30 |
| Gabapentin | 29 | $569 | $20 |
| Alprazolam | 40 | $497 | $12 |
| Clonazepam | 46 | $462 | $10 |
| Bupropion Hcl Sr | 14 | $447 | $32 |
| Risperidone | 18 | $434 | $24 |
| Bupropion Xl | 16 | $418 | $26 |
| Divalproex | 25 | $355 | $14 |
| Lorazepam | 20 | $338 | $17 |
| Quetiapine | 11 | $238 | $22 |
| Lamotrigine | 15 | $179 | $12 |
| Escitalopram | 12 | $160 | $13 |
| Methylphenidate Er | 11 | $152 | $14 |
| Hydromorphone | 25 | $138 | $6 |
| Eszopiclone | 12 | $104 | $9 |
| Sertraline | 23 | $82 | $4 |
2021: 16 drugs
| Buprenorphine-Naloxone | 24 | $4,153 | $173 |
| Buprenorphine | 27 | $1,167 | $43 |
| Olanzapine | 24 | $942 | $39 |
| Dextroamphetamine-Amphetamine | 18 | $820 | $46 |
| Trazodone | 23 | $400 | $17 |
| Lorazepam | 28 | $347 | $12 |
| Clonazepam | 37 | $289 | $8 |
| Risperidone | 39 | $254 | $7 |
| Alprazolam | 22 | $249 | $11 |
| Gabapentin | 17 | $248 | $15 |
| Divalproex | 21 | $193 | $9 |
| Eszopiclone | 14 | $149 | $11 |
| Quetiapine | 22 | $137 | $6 |
| Lamotrigine | 11 | $91 | $8 |
| Hydromorphone | 23 | $79 | $3 |
| Sertraline | 11 | $29 | $3 |
2020: 15 drugs
| Buprenorphine | 22 | $2,810 | $128 |
| Buprenorphine-Naloxone | 16 | $2,361 | $148 |
| Gabapentin | 27 | $766 | $28 |
| Alprazolam | 23 | $758 | $33 |
| Olanzapine Odt | 13 | $734 | $56 |
| Lorazepam | 39 | $415 | $11 |
| Tizanidine | 12 | $282 | $24 |
| Pregabalin | 15 | $271 | $18 |
| Trazodone | 25 | $232 | $9 |
| Risperidone | 40 | $192 | $5 |
| Aripiprazole | 13 | $188 | $14 |
| Lamotrigine | 14 | $160 | $11 |
| Eszopiclone | 13 | $155 | $12 |
| Diazepam | 21 | $145 | $7 |
| Divalproex | 16 | $109 | $7 |
2019: 10 drugs
| Buprenorphine | 13 | $1,111 | $85 |
| Ziprasidone | 18 | $818 | $45 |
| Alprazolam | 11 | $543 | $49 |
| Olanzapine Odt | 13 | $436 | $34 |
| Gabapentin | 20 | $403 | $20 |
| Lorazepam | 20 | $350 | $18 |
| Trazodone | 13 | $329 | $25 |
| Eszopiclone | 14 | $275 | $20 |
| Fluoxetine | 13 | $259 | $20 |
| Quetiapine | 15 | $186 | $12 |
2018: 10 drugs
| Olanzapine Odt | 13 | $862 | $66 |
| Trazodone | 13 | $511 | $39 |
| Methadone | 16 | $504 | $32 |
| Gabapentin | 21 | $399 | $19 |
| Lorazepam | 23 | $336 | $15 |
| Quetiapine | 20 | $315 | $16 |
| Eszopiclone | 13 | $215 | $17 |
| Fluoxetine | 17 | $140 | $8 |
| Zolpidem | 11 | $130 | $12 |
| Escitalopram | 12 | $111 | $9 |
2017: 15 drugs
| Rozerem | 13 | $4,496 | $346 |
| Thiothixene | 11 | $1,578 | $143 |
| Methadone | 12 | $818 | $68 |
| Buprenorphine | 16 | $780 | $49 |
| Trazodone | 13 | $453 | $35 |
| Fluoxetine | 14 | $365 | $26 |
| Quetiapine | 28 | $346 | $12 |
| Gabapentin | 17 | $319 | $19 |
| Lorazepam | 16 | $263 | $16 |
| Benztropine Mesylate | 15 | $171 | $11 |
| Zolpidem | 15 | $166 | $11 |
| Eszopiclone | 11 | $153 | $14 |
| Doxepin | 13 | $146 | $11 |
| Levothyroxine | 11 | $144 | $13 |
| Escitalopram | 13 | $29 | $2 |
2016: 13 drugs
| Lyrica | 14 | $7,152 | $511 |
| Rozerem | 14 | $4,663 | $333 |
| Buprenorphine | 31 | $2,458 | $79 |
| Mirtazapine | 15 | $532 | $35 |
| Quetiapine | 32 | $442 | $14 |
| Trazodone | 13 | $338 | $26 |
| Lorazepam | 19 | $225 | $12 |
| Doxepin | 14 | $188 | $13 |
| Benztropine Mesylate | 16 | $162 | $10 |
| Bupropion Hcl Sr | 12 | $151 | $13 |
| Zolpidem | 11 | $131 | $12 |
| Escitalopram | 14 | $42 | $3 |
| Citalopram Hbr | 16 | $38 | $2 |
2015: 15 drugs
| Latuda | 22 | $17,821 | $810 |
| Rozerem | 19 | $7,644 | $402 |
| Lyrica | 13 | $5,855 | $450 |
| Methylphenidate Er | 11 | $3,644 | $331 |
| Buprenorphine | 35 | $2,880 | $82 |
| Thiothixene | 11 | $861 | $78 |
| Quetiapine | 31 | $311 | $10 |
| Eszopiclone | 11 | $303 | $28 |
| Mirtazapine | 21 | $255 | $12 |
| Doxepin | 17 | $242 | $14 |
| Lorazepam | 21 | $175 | $8 |
| Trazodone | 17 | $159 | $9 |
| Fluoxetine | 12 | $140 | $12 |
| Diazepam | 11 | $95 | $9 |
| Citalopram Hbr | 24 | $88 | $4 |
2014: 15 drugs
| Rozerem | 16 | $7,254 | $453 |
| Suboxone | 17 | $6,948 | $409 |
| Lyrica | 13 | $4,769 | $367 |
| Buprenorphine | 21 | $2,237 | $107 |
| Thiothixene | 13 | $860 | $66 |
| Olanzapine | 22 | $664 | $30 |
| Quetiapine | 35 | $461 | $13 |
| Risperidone | 15 | $266 | $18 |
| Bupropion Hcl Sr | 13 | $219 | $17 |
| Lorazepam | 19 | $215 | $11 |
| Doxepin | 18 | $173 | $10 |
| Gabapentin | 24 | $172 | $7 |
| Citalopram Hbr | 22 | $103 | $5 |
| Trazodone | 15 | $101 | $7 |
| Zolpidem | 14 | $73 | $5 |
2013: 10 drugs
| Lyrica | 14 | $4,324 | $309 |
| Buprenorphine | 18 | $2,863 | $159 |
| Olanzapine | 21 | $1,110 | $53 |
| Quetiapine | 35 | $661 | $19 |
| Lorazepam | 21 | $279 | $13 |
| Bupropion Hcl Sr | 16 | $259 | $16 |
| Gabapentin | 25 | $199 | $8 |
| Citalopram Hbr | 23 | $161 | $7 |
| Trazodone | 19 | $121 | $6 |
| Zolpidem | 13 | $62 | $5 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2019 | 1 | 1 | None | $30 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $22 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-03-18 | Ozempic | $22 |
See earlier years (2019)
2019: $30
| Neuronetics | Neurostar Tms Therapy | $30 | 1 payment
|
Professional record
- NPI
- 1881714517
- Licence
- CA C34133California C34133: Surrendered
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 101YA0400X (101YA0400X); Federal specialty code 2084P0802X (2084P0802X)
- Mailing address
- 2512 Samaritan Ct, Ste M, San Jose, CA, 95124
- NPI first listed
- 2007-03-29
- NPI last updated
- 2017-04-25
This is when the NPI record was last certified, not a medical board exam.